-transparent.png){kind=logo}
Some analogues of (+/-)-N-methyl-N-¿1-[3-(4-fluorophenoxy)-2-hydroxy-propyl]-piperidin+ ++-4-yl¿ benzothiazol-2-amine (sabeluzole, CAS 104383-17-7), a series of 4-(l-naphthylamino)-piperidines (1a-1h), are potent inhibitors of both NADPH- and Fe(2+)-dependent lipid peroxidation (IC50 < 10 mumol/1). It was demonstrated that the naphthylaminopiperidine moiety is responsible for this effect due to its antioxidant property, verified by cyclic voltammetric studies.
Related Publications
G Domány, and
G Barta-Szalai, and
A Gere, and
G Farsang, and
I Schön
February 2001,
Bioorganic & medicinal chemistry letters,
G Domány, and
G Barta-Szalai, and
A Gere, and
G Farsang, and
I Schön
December 1994,
The Journal of pharmacy and pharmacology,
G Domány, and
G Barta-Szalai, and
A Gere, and
G Farsang, and
I Schön
September 2003,
Chemistry and physics of lipids,
G Domány, and
G Barta-Szalai, and
A Gere, and
G Farsang, and
I Schön
July 1966,
Lipids,
G Domány, and
G Barta-Szalai, and
A Gere, and
G Farsang, and
I Schön
February 2014,
Bioorganic & medicinal chemistry letters,
G Domány, and
G Barta-Szalai, and
A Gere, and
G Farsang, and
I Schön
February 1992,
Journal of medicinal chemistry,
G Domány, and
G Barta-Szalai, and
A Gere, and
G Farsang, and
I Schön
February 2001,
Bioorganic & medicinal chemistry letters,
G Domány, and
G Barta-Szalai, and
A Gere, and
G Farsang, and
I Schön
April 1983,
Journal of medicinal chemistry,
G Domány, and
G Barta-Szalai, and
A Gere, and
G Farsang, and
I Schön
January 1976,
Acta poloniae pharmaceutica,
G Domány, and
G Barta-Szalai, and
A Gere, and
G Farsang, and
I Schön
January 1974,
Acta poloniae pharmaceutica,
